Technology | September 13, 2007

MammoTest Offers Enhanced Access, Imaging Quality in Breast Biopsy

Siemens Medical Solutions’ fully digital prone table, MammoTest, has expanded Siemens’ biopsy portfolio by offering clinicians the choice of upright or prone stereotactic systems.

Based on the Fischer Imaging design, the MammoTest features a polar coordinate system that offers angled access and unobstructed views to all breast areas, enabling true all-angles and 360-degree patient and lesion access. Polar coordinate targeting and a high resolution fiber optic camera enable an increased number of biopsies to be performed, enhancing facility workflow and throughput. Its versatility also allows for handheld ultrasound biopsy and needle localizations.

MammoTest’s ergonomic table design allows the patient to rest in the more comfortable prone position, while its rotating gantry eliminates the need to reposition the patient during the examination. At 11 inches, the system’s central breast aperture is the largest in the industry and enables enhanced access to lesions high up the axilla region.

As with Opdima, Siemens’ combined spot-imaging and stereotactic biopsy system, the MammoTest offers all the advantages of a minimally invasive intervention.

Related Content

FDA Clears Ion Endoluminal Lung Biopsy System
Technology | Interventional Radiology | February 20, 2019
The U.S. Food and Drug Administration (FDA) cleared the Ion endoluminal system from Intuitive Surgical Inc. to enable...
Micro-Ultrasound and Artificial Intelligence Combining to Detect Prostate Cancer
News | Prostate Cancer | February 12, 2019
Cambridge Consultants has partnered with Exact Imaging, makers of the ExactVu micro-ultrasound platform, as the two...
Novel Technique May Significantly Reduce Breast Biopsies
News | Breast Biopsy Systems | January 17, 2019
A novel technique that uses mammography to determine the biological tissue composition of a tumor could help reduce...
Biomarker blood test accurately confirms remission in non-smoker with HPV-associated oral cancer. ASTRO 2018 #ASTRO2018 #ASTRO #ASTRO18

Biomarker blood test accurately confirms remission in non-smoker with HPV-associated oral cancer.

News | Radiation Oncology | October 30, 2018
October 30, 2018 — A highly sensitive blood test that detects minute traces of cancer-specific DNA has been shown to
Leica Biosystems Launches MammoPort Specimen Containment and Transport System
Technology | Breast Biopsy Systems | October 03, 2018
Leica Biosystems announced the U.S. launch of MammoPort, the first integrated specimen containment and transport system...
Exact Imaging Partners to Improve Prostate Cancer Detection With Artificial Intelligence
News | Prostate Cancer | September 19, 2018
Exact Imaging, makers of the ExactVu micro-ultrasound platform, has partnered with U.K.-based Cambridge Consultants to...
Exact Imaging Becomes UroGPO Imaging Partner
News | Ultrasound Imaging | August 10, 2018
Exact Imaging announced that it has become a UroGPO Imaging Partner, joining the North American urology-specific group...
Technology | Focused Ultrasound Therapy | June 19, 2018
EDAP TMS SA has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Focal One device for...
Hitachi Medical Systems Europe Named Imaging Supplier for London Prostate Cancer Program
News | Prostate Cancer | June 14, 2018
Hitachi Medical Systems Europe has been awarded the contract to supply six ultrasound systems as part of the RAPID...